세계의 폐수 감시 시장 : 제품별, 용도별, 최종 사용자별 예측(-2030년)

The global wastewater surveillance market is projected to reach USD 1.22 billion by 2030, up from an estimated USD 0.88 billion in 2025, at a CAGR of 6.7% during the forecast period. This market growth is driven by various factors, including the increasing need for early detection of public health threats, more government initiatives and funding for wastewater-based epidemiology, and technological advances in molecular diagnostics and sequencing platforms.

The COVID-19 pandemic has further confirmed the importance of wastewater surveillance as a dependable tool for monitoring community-level disease outbreaks. Wastewater surveillance is expanding beyond pandemic tracking to encompass antimicrobial resistance, illicit drug consumption patterns, and industrial pollution. The use of smart sensors, cloud-based data analytics, and automated sampling systems is making surveillance more scalable and cost-effective. These developments, along with rising public-private collaborations and regulatory support, are expected to propel the ongoing adoption of wastewater-based monitoring systems globally.

"Software solutions are expected to register the highest CAGR in the product type market during the study period."

Software solutions are expected to see the highest growth in the wastewater surveillance market due to the increasing demand for real-time data analytics, automated reporting, and predictive modeling. As surveillance programs expand, the volume of data generated from pathogen detection, sampling sites, and temporal trends is increasing rapidly, making manual processing inefficient. Advanced software platforms enable seamless integration of laboratory results, GIS mapping, trend visualization, and AI-based outbreak prediction, which greatly improves decision-making and response times. Governments, utilities, and research institutions are investing in digital infrastructure to enhance surveillance accuracy, optimize resource use, and meet regulatory requirements. Additionally, the move toward smart city development and digital public health systems across the Asia Pacific, North America, and Europe is boosting the demand for scalable, interoperable software solutions. Cloud-based platforms also support centralized monitoring across multiple sites, making them highly attractive for regional and national programs. As stakeholders focus on cost-efficiency, real-time insights, and actionable intelligence, software will play a crucial role in expanding wastewater surveillance systems worldwide.

"The government & regulatory agency held the largest share of the wastewater surveillance end user market in 2024."

Governments and regulatory agencies dominate the wastewater surveillance market because of their key role in public health, environmental protection, and epidemic response. These organizations mainly oversee the monitoring and control of infectious diseases, water safety, and the enforcement of environmental laws. They fund large-scale surveillance initiatives, require pathogen testing in wastewater, and often implement early warning systems to monitor community health. During global health emergencies like the COVID-19 pandemic, many nations used wastewater-based epidemiology as a cost-effective, non-invasive way to identify outbreaks. Regulatory agencies also collaborate with research institutions and private companies to standardize testing procedures and incorporate data into national health plans. Their capacity to manage budgets, expand infrastructure, and enforce policies grants them significant influence, making them the largest and most consistent users in the market.

"The Asia Pacific regional segment is expected to register the highest CAGR in the wastewater surveillance regional market during the forecast period."

The Asia Pacific region is expected to achieve the highest CAGR in the wastewater surveillance market due to a mix of environmental, healthcare, and infrastructural factors. Rapid urbanization and industrialization have significantly increased wastewater production across countries like China, India, Indonesia, and Vietnam, creating a need for better monitoring systems to protect the environment and public health. Governments in the area are increasingly adopting wastewater-based epidemiology (WBE) to monitor infectious diseases such as COVID-19 and antimicrobial resistance, especially in densely populated urban centers. Countries like Japan and South Korea are already integrating wastewater surveillance into their broader disease control strategies. Additionally, the growth of smart city projects and digital water infrastructure is enabling real-time pathogen tracking and early outbreak detection. Meanwhile, rising awareness about the importance of environmental diagnostics and sustainability is boosting demand for innovative solutions such as PCR-based detection kits, biosensors, and data analytics platforms. The region's large population, increasing health surveillance requirements, and new environmental compliance policies all contribute to its strong growth prospects in the wastewater surveillance market.

A breakdown of the primary participants referred to for this report is provided below:

• By Company: Tier 1 (35%), Tier 2 (45%), and Tier 3 (20%)
• By Designation: C-level Executives (35%), Director-level Executives (25%), and Others (40%)
• By Region: North America (40%), Europe (30%), Asia Pacific (20%), Latin America (5%), and the Middle East & Africa (5%)

Prominent players in the waste water surveillance market include Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), IDEXX Laboratories (US), Eurofins Scientific (Luxembourg), GT Molecular (US), Illumina (US), Oxford Nanopore (UK), Hach (Danaher) (US), Teledyne ISCO (US), LuminUltra (Canada), Biobot Analytics (US), Modern Water (DeepVerge) (UK), Promega (US), Aquamonitrix (Ireland), PathogenDx (US), Zymo Research (US), Kando (Israel), 4sight Analytics (US), among others.

Research Coverage

• The report studies the wastewater surveillance market based on brand, product type, procedure, end user, and region.
• The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting market growth.
• The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders.
• The report studies micro markets with respect to their growth trends, prospects, and contributions to the global wastewater surveillance market.
• The report forecasts the revenue of market segments with respect to five major regions.

Key Benefits of Buying this Report

This report is valuable for both new and existing players in the market, providing essential information to identify potential investment opportunities. It offers a comprehensive overview of both major and minor competitors, aiding effective risk analysis and informed investment choices. The report features detailed segmentation based on end users and geographic regions, giving in-depth insights into niche market segments. Additionally, it highlights key trends, growth drivers, challenges, and opportunities, supporting strategic decision-making with a balanced perspective analysis.

Through this report, readers get insightful views into the following parameters:

• Analysis of key drivers (increasing need for early detection of public health threats, government funding for pandemic preparedness, and integration of wastewater data into national disease surveillance systems), restraints (high operational costs, lack of standardization in testing protocols, and limited infrastructure in low-resource regions), opportunities (expansion of surveillance beyond COVID-19 to antimicrobial resistance, pharmaceutical residues, and industrial pollutants; growing interest from private and municipal stakeholders), challenges (data interpretation complexity, lack of trained personnel, regulatory ambiguity, and difficulty in integrating surveillance findings into actionable public health responses), relating to the growth of the wastewater surveillance market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the wastewater surveillance market.
• Market Development: Comprehensive information about lucrative markets - the report analyses the wastewater surveillance market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the wastewater surveillance market
• Competitive Assessment: A comprehensive analysis of market share, product offerings, and leading strategies of major players, such as Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), IDEXX Laboratories (US), Eurofins Scientific (Luxembourg), GT Molecular (US), Illumina (US), Oxford Nanopore (UK), Hach (Danaher) (US), Teledyne ISCO (US), LuminUltra (Canada), Biobot Analytics (US), Modern Water (DeepVerge) (UK), Promega (US), Aquamonitrix (Ireland), PathogenDx (US), Zymo Research (US), Kando (Israel), 4sight Analytics (US)

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
• 1.4 STAKEHOLDERS

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY RESEARCH
    • 2.1.1.1 Key secondary sources
    • 2.1.1.2 Key data from secondary sources
    • 2.1.1.3 Objectives of secondary research
  • 2.1.2 PRIMARY RESEARCH
    • 2.1.2.1 Key primary sources
    • 2.1.2.2 List of key participants
    • 2.1.2.3 Breakdown of primary interviews
    • 2.1.2.4 Objectives of primary research
    • 2.1.2.5 Insights from industry experts
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 BOTTOM-UP APPROACH
    • 2.2.1.1 Company revenue estimation
    • 2.2.1.2 Customer-based market estimation
    • 2.2.1.3 Primary interviews
  • 2.2.2 TOP-DOWN APPROACH
• 2.3 DATA TRIANGULATION
• 2.4 STUDY ASSUMPTIONS
• 2.5 RESEARCH LIMITATIONS
• 2.6 RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 WASTEWATER SURVEILLANCE MARKET OVERVIEW
• 4.2 WASTEWATER SURVEILLANCE MARKET, BY REGION
• 4.3 ASIA PACIFIC: WASTEWATER SURVEILLANCE MARKET, BY COUNTRY AND END USER
• 4.4 GEOGRAPHIC SNAPSHOT OF WASTEWATER SURVEILLANCE MARKET

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Increased institutional rollout and official government programs
    • 5.2.1.2 Broader pathogen scope and public-health adoption
    • 5.2.1.3 Faster and cheaper molecular and sequencing technologies
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Fragmented procurement and limited long-term budgets
    • 5.2.2.2 Analytical and interpretation complexity
    • 5.2.2.3 Lack of global sampling, processing, and reporting standardization and comparability
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Integration of wastewater surveillance with digital epidemiology and AI analytics
    • 5.2.3.2 Expansion to multi-parameter public health and environmental intelligence platform from pandemic-driven pathogen monitoring tool
    • 5.2.3.3 Scaling WBE programs in low- and middle-income countries (LMICs)
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Fragmented regulatory framework and lack of global standardization
    • 5.2.4.2 High operational costs and infrastructure limitations in resource-poor settings
    • 5.2.4.3 Data privacy concerns and public acceptance barriers
• 5.3 TECHNOLOGY ANALYSIS
  • 5.3.1 KEY TECHNOLOGIES
    • 5.3.1.1 Automated composite sampling systems
    • 5.3.1.2 qPCR and digital PCR platforms
    • 5.3.1.3 Next-generation sequencing
  • 5.3.2 COMPLEMENTARY TECHNOLOGIES
    • 5.3.2.1 Geographic information systems
    • 5.3.2.2 Internet of things (IoT) and remote sensing devices
    • 5.3.2.3 Cloud-based data analytics platforms
  • 5.3.3 ADJACENT TECHNOLOGIES
    • 5.3.3.1 Clinical diagnostics (PCR and rapid antigen testing)
    • 5.3.3.2 Genomic epidemiology (pathogen sequencing)
• 5.4 SUPPLY CHAIN ANALYSIS
  • 5.4.1 PROMINENT PLAYERS
  • 5.4.2 SMALL AND MEDIUM-SIZED ENTERPRISES
  • 5.4.3 SALES & DISTRIBUTION PARTNERS
  • 5.4.4 END USERS
• 5.5 PORTER'S FIVE FORCES ANALYSIS
  • 5.5.1 THREAT OF NEW ENTRANTS
  • 5.5.2 THREAT OF SUBSTITUTES
  • 5.5.3 BARGAINING POWER OF SUPPLIERS
  • 5.5.4 BARGAINING POWER OF BUYERS
  • 5.5.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.6 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.6.1 KEY STAKEHOLDERS IN BUYING PROCESS, BY PRODUCT
  • 5.6.2 KEY BUYING CRITERIA
• 5.7 PATENT ANALYSIS
  • 5.7.1 WASTEWATER SURVEILLANCE MARKET: TOP 10 APPLICANTS/COMPANIES WITH HIGHEST NUMBER OF PATENTS, JANUARY 2015-APRIL 2025
  • 5.7.2 LIST OF MAJOR PATENTS
• 5.8 KEY CONFERENCES & EVENTS, 2025-2026
• 5.9 TRADE DATA ANALYSIS
  • 5.9.1 IMPORT DATA FOR HS CODE 8479
  • 5.9.2 EXPORT DATA FOR HS CODE 8479
• 5.10 UNMET NEEDS & KEY PAIN POINTS
• 5.11 ECOSYSTEM ANALYSIS
  • 5.11.1 ROLE OF ECOSYSTEM
• 5.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
• 5.13 INVESTMENT & FUNDING SCENARIO
• 5.14 IMPACT OF AI/GEN AI ON WASTEWATER SURVEILLANCE MARKET
• 5.15 REGULATORY ANALYSIS
  • 5.15.1 REGULATORY LANDSCAPE
    • 5.15.1.1 North America
      • 5.15.1.1.1 US
      • 5.15.1.1.2 Canada
    • 5.15.1.2 Europe
      • 5.15.1.2.1 European Union (UWWTD / IVDR interplay)
      • 5.15.1.2.2 UK
      • 5.15.1.2.3 Germany
      • 5.15.1.2.4 France
      • 5.15.1.2.5 Italy
      • 5.15.1.2.6 Spain
      • 5.15.1.2.7 Netherlands (RIVM)
    • 5.15.1.3 Asia Pacific
      • 5.15.1.3.1 China
      • 5.15.1.3.2 India
      • 5.15.1.3.3 Australia
      • 5.15.1.3.4 Japan
      • 5.15.1.3.5 South Korea
    • 5.15.1.4 Latin America
      • 5.15.1.4.1 Brazil
      • 5.15.1.4.2 Mexico
      • 5.15.1.4.3 Argentina
      • 5.15.1.4.4 Chile
      • 5.15.1.4.5 Colombia
  • 5.15.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 5.16 PRICING ANALYSIS
  • 5.16.1 AVERAGE SELLING PRICE TREND OF WASTEWATER SURVEILLANCE PRODUCTS, BY REGION, 2022-2024
  • 5.16.2 AVERAGE SELLING PRICE OF WASTEWATER SURVEILLANCE PRODUCTS, BY KEY PLAYER, 2024
• 5.17 IMPACT OF 2025 US TARIFF ON WASTEWATER SURVEILLANCE MARKET
  • 5.17.1 INTRODUCTION
  • 5.17.2 KEY TARRIF RATES
  • 5.17.3 PRICE IMPACT ANALYSIS
  • 5.17.4 IMPACT ON COUNTRY/REGION
    • 5.17.4.1 North America
    • 5.17.4.2 Europe
    • 5.17.4.3 Asia Pacific
  • 5.17.5 IMPACT ON END-USE INDUSTRIES
    • 5.17.5.1 Municipal utilities
    • 5.17.5.2 Public health agencies
    • 5.17.5.3 Industrial dischargers (F&B and pharma/biotech plants)
    • 5.17.5.4 Academic & research institutes
    • 5.17.5.5 Private labs & service providers

6 WASTEWATER SURVEILLANCE MARKET, BY PRODUCT

• 6.1 INTRODUCTION
• 6.2 INSTRUMENTS & EQUIPMENT
  • 6.2.1 AUTOMATED WASTEWATER SAMPLERS
    • 6.2.1.1 Automated samplers to be indispensable for accurate infectious disease monitoring, AMR tracking, and chemical residue detection
  • 6.2.2 SAMPLE FILTRATION & ULTRACENTRIFUGATION
    • 6.2.2.1 Technological innovations to reduce variability and make large-scale wastewater surveillance programs more reproducible
  • 6.2.3 PCR & QPCR INSTRUMENTS
    • 6.2.3.1 PCR & qPCR instruments to enable sensitive detection of microbial targets from complex environmental samples
  • 6.2.4 NGS SEQUENCERS
    • 6.2.4.1 Expansion of surveillance beyond single pathogens for AMR and new viral threats by government bodies to speed up adoption
  • 6.2.5 PORTABLE FIELD-TESTING DEVICES
    • 6.2.5.1 Portable field-testing devices to allow quick on-site detection of pathogens without centralized lab facilities
• 6.3 DETECTION ASSAYS & TESTING KITS
  • 6.3.1 VIRAL PATHOGEN DETECTION KITS
    • 6.3.1.1 Need for improved sensitivity in low-viral-load wastewater samples to increase demand for high-throughput, multiplexed detection kits
  • 6.3.2 BACTERIAL DETECTION KITS
    • 6.3.2.1 Favorable regulatory policies to spur growth for food safety, healthcare-associated infections, and antimicrobial resistance surveillance
  • 6.3.3 AMR GENE PANELS
    • 6.3.3.1 Growing integration of ML and bioinformatics tools to enable predictive modelling of resistance emergence
  • 6.3.4 SUBSTANCE & PHARMACEUTICAL RESIDUE DETECTION KITS
    • 6.3.4.1 Need for enhanced wastewater contaminant detection capabilities to fuel market adoption
  • 6.3.5 OTHER ASSAY KITS & PANELS
• 6.4 SOFTWARE
  • 6.4.1 INCREASED DEPENDENCY ON CLOUD-BASED WASTEWATER ANALYTICS FOR EARLY OUTBREAK ALERTS TO BOOST MARKET GROWTH
• 6.5 CONSUMABLES & ACCESSORIES
  • 6.5.1 COMPLEXITY OF WASTEWATER MATRICES TO PROPEL ADOPTION FOR MAXIMIZED YIELD, PURITY, AND REPRODUCIBILITY

7 WASTEWATER SURVEILLANCE MARKET, BY APPLICATION

• 7.1 INTRODUCTION
• 7.2 INFECTIOUS DISEASE SURVEILLANCE
  • 7.2.1 NATIONAL WASTEWATER SURVEILLANCE PROGRAMS TO MAKE WASTEWATER MONITORING ESSENTIAL FOR BETTER PUBLIC HEALTH
• 7.3 ANTIMICROBIAL RESISTANCE (AMR) MONITORING
  • 7.3.1 INTEGRATION OF ANTIMICROBIAL RESISTANCE MONITORING INTO PUBLIC HEALTH PROGRAMS TO EASE GLOBAL CRISIS MANAGEMENT
• 7.4 INDUSTRIAL & ENVIRONMENTAL POLLUTION DETECTION
  • 7.4.1 FAVORABLE GOVERNMENT INITIATIVES AND INCREASED PRIVATE INVESTMENTS TO BOOST MARKET GROWTH
• 7.5 OTHER APPLICATIONS

8 WASTEWATER SURVEILLANCE MARKET, BY END USER

• 8.1 INTRODUCTION
• 8.2 GOVERNMENT & REGULATORY AGENCIES
  • 8.2.1 FAVORABLE POLICY MANDATES AND HIGH INVESTMENTS IN SURVEILLANCE INFRASTRUCTURE TO DRIVE MARKET
• 8.3 PUBLIC HEALTH AUTHORITIES
  • 8.3.1 PUBLIC HEALTH AUTHORITIES TO TRANSFORM WASTEWATER DATA INTO REAL-TIME INTELLIGENCE FOR BETTER OUTBREAK DETECTION
• 8.4 RESEARCH & ACADEMIC INSTITUTES
  • 8.4.1 INCREASED METHODOLOGICAL INNOVATION AND STANDARDIZATION IN WASTEWATER-BASED EPIDEMIOLOGY TO PROPEL MARKET GROWTH
• 8.5 WASTEWATER TREATMENT PLANTS
  • 8.5.1 WASTEWATER TREATMENT PLANTS TO EMERGE AS OPERATIONAL BACKBONE OF GLOBAL LARGE-SCALE SURVEILLANCE NETWORKS
• 8.6 CONTRACT TESTING & ANALYTICAL LABORATORIES
  • 8.6.1 CONTRACT TESTING & ANALYTICAL LABORATORIES TO SCALE HIGH-THROUGHPUT CAPACITY FOR PATHOGEN AND BIOMARKER SURVEILLANCE
• 8.7 OTHER END USERS

9 WASTEWATER SURVEILLANCE MARKET, BY REGION

• 9.1 INTRODUCTION
• 9.2 NORTH AMERICA
  • 9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 9.2.2 US
    • 9.2.2.1 US to dominate North American wastewater surveillance market during forecast period
  • 9.2.3 CANADA
    • 9.2.3.1 Popularity of advanced sequencing technologies and strong federal-provincial collaboration to boost market growth
• 9.3 EUROPE
  • 9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 9.3.2 GERMANY
    • 9.3.2.1 Focus on advanced detection tools with enhanced readiness against public health threats to support market growth
  • 9.3.3 FRANCE
    • 9.3.3.1 Increased recognition of wastewater-based epidemiology as cost-effective and non-invasive monitoring tool to drive market
  • 9.3.4 UK
    • 9.3.4.1 Expansion of wastewater surveillance use from infectious diseases to public health intelligence to fuel market growth
  • 9.3.5 ITALY
    • 9.3.5.1 Advancement in PCR assays to bring innovation in wastewater Surveillance
  • 9.3.6 SPAIN
    • 9.3.6.1 Need for early detection of outbreaks to propel adoption of wastewater surveillance products
  • 9.3.7 REST OF EUROPE
• 9.4 ASIA PACIFIC
  • 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 9.4.2 CHINA
    • 9.4.2.1 Advanced automation solutions by key players to expand surveillance in antimicrobial resistance and enteric pathogens
  • 9.4.3 JAPAN
    • 9.4.3.1 Strong research ecosystem, high public health awareness, and widespread support for early-warning systems to drive market
  • 9.4.4 INDIA
    • 9.4.4.1 Increasing need for early detection of infectious diseases to drive adoption of antimicrobial resistance surveillance
  • 9.4.5 AUSTRALIA
    • 9.4.5.1 Popularity of National Wastewater Surveillance Program for priority and emerging pathogen tracking to drive market
  • 9.4.6 SOUTH KOREA
    • 9.4.6.1 Long-term monitoring programs to drive wastewater surveillance for tracking infectious pathogens and antimicrobial resistance
  • 9.4.7 REST OF ASIA PACIFIC
• 9.5 LATIN AMERICA
  • 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 9.5.2 BRAZIL
    • 9.5.2.1 Supportive government initiatives and high sanitation investments to support market growth
  • 9.5.3 MEXICO
    • 9.5.3.1 Favorable business environment for market players and focus on integrating wastewater-based epidemiology to aid market growth
  • 9.5.4 REST OF LATIN AMERICA
• 9.6 MIDDLE EAST & AFRICA
  • 9.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 9.6.2 GCC COUNTRIES
    • 9.6.2.1 Shift from single-pathogen monitoring to multi-pathogen and AMR-focused surveillance to propel market growth
  • 9.6.3 REST OF MIDDLE EAST & AFRICA

10 COMPETITIVE LANDSCAPE

• 10.1 INTRODUCTION
• 10.2 KEY PLAYERS' STRATEGIES/RIGHT TO WIN
  • 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN WASTEWATER SURVEILLANCE MARKET
• 10.3 REVENUE ANALYSIS, 2020-2024
• 10.4 MARKET SHARE ANALYSIS, 2024
  • 10.4.1 MARKET RANKING OF KEY PLAYERS
• 10.5 COMPANY VALUATION & FINANCIAL METRICS
  • 10.5.1 FINANCIAL METRICS
  • 10.5.2 COMPANY VALUATION
• 10.6 BRAND/PRODUCT COMPARISON
• 10.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  • 10.7.1 STARS
  • 10.7.2 EMERGING LEADERS
  • 10.7.3 PERVASIVE PLAYERS
  • 10.7.4 PARTICIPANTS
  • 10.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
    • 10.7.5.1 Company footprint
    • 10.7.5.2 Region footprint
    • 10.7.5.3 Product footprint
    • 10.7.5.4 Application footprint
    • 10.7.5.5 End-user footprint
• 10.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
  • 10.8.1 PROGRESSIVE COMPANIES
  • 10.8.2 RESPONSIVE COMPANIES
  • 10.8.3 DYNAMIC COMPANIES
  • 10.8.4 STARTING BLOCKS
  • 10.8.5 COMPETITIVE BENCHMARKING OF STARTUPS/SMES, 2024
    • 10.8.5.1 Detailed list of key startups/SMEs
    • 10.8.5.2 Competitive benchmarking of key startups/SMEs
• 10.9 COMPETITIVE SCENARIO
  • 10.9.1 PRODUCT LAUNCHES
  • 10.9.2 DEALS
  • 10.9.3 EXPANSIONS

11 COMPANY PROFILES

• 11.1 KEY PLAYERS
  • 11.1.1 BECKMAN COULTER, INC. (DANAHER CORPORATION)
    • 11.1.1.1 Business overview
    • 11.1.1.2 Products/Services/Solutions offered
    • 11.1.1.3 MnM view
      • 11.1.1.3.1 Right to win
      • 11.1.1.3.2 Strategic choices
      • 11.1.1.3.3 Weaknesses & competitive threats
  • 11.1.2 MERCK KGAA
    • 11.1.2.1 Business overview
    • 11.1.2.2 Products/Services/Solutions offered
    • 11.1.2.3 MnM view
      • 11.1.2.3.1 Right to win
      • 11.1.2.3.2 Strategic choices
      • 11.1.2.3.3 Weaknesses & competitive threats
  • 11.1.3 THERMO FISHER SCIENTIFIC INC.
    • 11.1.3.1 Business overview
    • 11.1.3.2 Products/Services/Solutions offered
    • 11.1.3.3 Recent developments
      • 11.1.3.3.1 Product launches
    • 11.1.3.4 MnM view
      • 11.1.3.4.1 Right to win
      • 11.1.3.4.2 Strategic choices
      • 11.1.3.4.3 Weaknesses & competitive threats
  • 11.1.4 ILLUMINA, INC.
    • 11.1.4.1 Business overview
    • 11.1.4.2 Products/Services/Solutions offered
    • 11.1.4.3 Recent developments
      • 11.1.4.3.1 Product launches
    • 11.1.4.4 MnM view
      • 11.1.4.4.1 Right to win
      • 11.1.4.4.2 Strategic choices
      • 11.1.4.4.3 Weaknesses & competitive threats
  • 11.1.5 IDEXX LABORATORIES
    • 11.1.5.1 Business overview
    • 11.1.5.2 Products/Services/Solutions offered
    • 11.1.5.3 MnM view
      • 11.1.5.3.1 Right to win
      • 11.1.5.3.2 Strategic choices
      • 11.1.5.3.3 Weaknesses & competitive threats
  • 11.1.6 TELEDYNE TECHNOLOGIES INCORPORATED
    • 11.1.6.1 Business overview
    • 11.1.6.2 Products/Services/Solutions offered
  • 11.1.7 EUROFINS SCIENTIFIC
    • 11.1.7.1 Business overview
    • 11.1.7.2 Products/Services/Solutions offered
    • 11.1.7.3 Recent developments
      • 11.1.7.3.1 Product launches
  • 11.1.8 BIO-RAD LABORATORIES, INC.
    • 11.1.8.1 Business overview
    • 11.1.8.2 Products/Services/Solutions offered
    • 11.1.8.3 Recent developments
      • 11.1.8.3.1 Product launches
      • 11.1.8.3.2 Deals
  • 11.1.9 BIOBOT ANALYTICS, INC.
    • 11.1.9.1 Business overview
    • 11.1.9.2 Products/Services/Solutions offered
    • 11.1.9.3 Recent developments
      • 11.1.9.3.1 Product launches
      • 11.1.9.3.2 Deals
  • 11.1.10 GT MOLECULAR
    • 11.1.10.1 Business overview
    • 11.1.10.2 Products/Services/Solutions offered
    • 11.1.10.3 Recent developments
      • 11.1.10.3.1 Product launches
      • 11.1.10.3.2 Deals
  • 11.1.11 PROMEGA CORPORATION
    • 11.1.11.1 Business overview
    • 11.1.11.2 Products/Services/Solutions offered
    • 11.1.11.3 Recent developments
      • 11.1.11.3.1 Expansions
  • 11.1.12 QIAGEN
    • 11.1.12.1 Business overview
    • 11.1.12.2 Products/Services/Solutions offered
    • 11.1.12.3 Recent developments
      • 11.1.12.3.1 Product launches
• 11.2 OTHER PLAYERS
  • 11.2.1 ZYMO RESEARCH CORPORATION
  • 11.2.2 CERES NANOSCIENCES, INC.
  • 11.2.3 FUSION GENOMICS CORPORATION
  • 11.2.4 LUMINULTRA
  • 11.2.5 ACLARITY, INC.
  • 11.2.6 VERMICON
  • 11.2.7 AQUATIC INFORMATICS ULC
  • 11.2.8 KANDO
  • 11.2.9 BLUEDOT INC.
  • 11.2.10 FLUIDION
  • 11.2.11 VELARTO
  • 11.2.12 OXFORD NANOPORE TECHNOLOGIES
  • 11.2.13 XYLEM

12 APPENDIX

• 12.1 DISCUSSION GUIDE
• 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 12.3 CUSTOMIZATION OPTIONS
• 12.4 RELATED REPORTS
• 12.5 AUTHOR DETAILS